Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Terminated 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Genitourinary 1

Conditions

Breast Neoplasms 8Lung Neoplasms 5Colorectal Neoplasms 3Prostatic Neoplasms 2Neoplasm Metastasis 2Melanoma 2Hot Flashes 2Glioblastoma 2Carcinoma, Non-Small-Cell Lung 2COVID-19 2Brain Neoplasms 2Water-Electrolyte Imbalance 1Ventilator-Induced Lung Injury 1Surgical Wound 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Severe Acute Respiratory Syndrome 1Rectal Neoplasms 1Postoperative Complications 1Pathologic Complete Response 1Neoplasm, Residual 1Mastocytosis 1Lymphopenia 1Lymphoma, Non-Hodgkin 1Lymphedema 1Lower Urinary Tract Symptoms 1Locally Advanced Head and Neck Squamous Cell Carcinoma 1Leukemia, Myeloid, Acute 1Leukemia, Hairy Cell 1Hypersensitivity 1

Interventions

Oxaliplatin 67Capecitabine 60Fluorouracil 58Bevacizumab 54Gemcitabine 51Paclitaxel 50Leucovorin 50Irinotecan 40Docetaxel 39Carboplatin 39Cisplatin 38pembrolizumab 37Nivolumab 37Cetuximab 35Sunitinib 25Trastuzumab 24Radiosurgery 24Radiotherapy 21Doxorubicin 21Cyclophosphamide 21Panitumumab 20Drug Therapy 19Pemetrexed 18Everolimus 18Sorafenib 17Interleukin-2 16Fulvestrant 16Albumin-Bound Paclitaxel 16atezolizumab 15Erlotinib Hydrochloride 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Neoplasm Metastasis × Sodium Chloride × Clear all
NCT04863248 2023-04-14

PRESERVE 4

G1 Therapeutics, Inc.

Phase 2 Terminated
10 enrolled 14 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

NCT00459654 2014-06-25

A Placebo-controlled Phase II Study of Bone-targeted Radium-223 in Symptomatic Hormone-refractory Prostate Cancer

Bayer

Phase 2 Completed
64 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡